How can eBR be implented on a global scale on all manufacturing lines?
What are the differences in biotechnology processing compared to one-batch manufacturing?
What are the main challenges regarding eBR for biotechnology?
How can a multi-active approach be employed to address diverse regulatory landscapes and operational complexities, ensuring a comprehensive and future-proof solution?